Pharmacy Medical Policy Updates
The following Pharmacy Medical Policy program has been updated March 1, 2023:
Effective April 1, 2023:
- Ampyra
- Multiple Sclerosis
- Healthcare Administered Multiple Sclerosis
- Kerendia
- Opzelura
- Spinraza
- SA Oncology
- Tezspire
- Zeposia
If you have any questions regarding this newsletter, please contact your BCBSKS provider representative/consultant.